Sulochana Khadka

Medical Student
Nepalese Army Institute of Health Sciences
Kathmandu, Bagmati, Nepal

Presentation(s):

• OC 42.5 - Hemorrhagic risk of Caplacizumab in the treatment of Thrombotic thrombocytopenic purpura A pharmacovigilance study from 2020-2022 FAERS Database.

  Monday, June 26, 2023
  15:45 – 16:00 ET